PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Massachusetts Institute of Technology IDs new cancer drug target

Shutting down enzyme that controls DNA repair could boost effects of traditional chemo drugs

2010-11-09
(Press-News.org) CAMBRIDGE, Mass. -- Suppressing cancer cells' ability to replicate damaged DNA could dramatically enhance the effectiveness of chemotherapy drugs such as cisplatin, according to a new pair of papers from MIT biologists.

In studies of mice, the researchers found that slowing down a specific system for tolerating DNA damage not only prolonged survival but also prevented relapsed tumors from becoming resistant to chemotherapy, and made tumors much less likely to spread to other parts of the body.

Two enzymes that play key roles in a cell's response to DNA damage could be an enticing target for new cancer drugs, according to Michael Hemann and Graham Walker, senior authors of the two papers. Their new findings will appear in the Proceedings of the National Academy of Sciences during the week of Nov. 8.

Many cancer drugs, including cisplatin, kill cancer cells by damaging their DNA. This damage can impair a cell's ability to copy its DNA before cell division, resulting in cell death. However, cancer cells use enzymes known as translesion DNA polymerases to copy over damaged DNA and prevent the newly replicated DNA from having gaps in its normal sequence of nucleotide bases (the "rungs" of the ladder that forms the DNA double helix).

In these studies, the MIT researchers focused on two proteins, known as Rev3 and Rev1, which are subunits of translesion DNA polymerases.

In one of the PNAS papers, Hemann and Walker studied mice with a particularly aggressive form of lung cancer. Among mice treated with cisplatin, mice whose Rev3 levels were reduced by 60 to 70 percent lived twice as long as mice with the normal amount of Rev3. (Mice with reduced Rev3 lived an average of 22.5 days following cisplatin treatment; mice treated with cisplatin alone lived 11 days.) This is the first alteration shown to sensitize these tumors to front-line chemotherapy.

Translesion polymerases can be highly error-prone and thus introduce mutations into DNA. This can lead to drug-resistant tumors. Consistent with this idea, the researchers showed in a companion study that lymphomas with reduced Rev1 levels did not become resistant to chemotherapy following treatment and were much less aggressive in spreading to other parts of the body.

In that study, the researchers treated mice with the drug cyclophosphamide. At first, the drug was effective in mice whose tumors had normal and reduced Rev1, but in both groups, tumors reappeared after about two weeks. This is similar to the relapse that frequently occurs during the treatment of many human cancers.

Those relapsed tumors were then transplanted into a second group of mice. In the second group, drug treatment was strikingly more effective in mice with reduced Rev1. Those mice survived much longer — 100 percent of the mice with reduced Rev1 lived for 12 days, whereas some of the mice with normal Rev1 level tumors died in two days and only 40 percent lived for 12 days. These experiments showed that reducing Rev1 levels prevented the tumor cells from acquiring drug resistance and aggressiveness when they relapse so that they can be successfully treated again.

The researchers' discoveries suggest that by inhibiting translesion DNA polymerases, it might be possible to treat difficult cancers that have proven resistant to ordinary chemotherapeutic treatments and also prevent the introduction of new mutations during chemotherapy.

In these studies, the researchers used a technique called RNA interference to block the expression of the genes that code for Rev3 and Rev1, but they were unable to shut off the genes completely.

### Walker, an American Cancer Society Research Professor of Biology at MIT, is now looking for drugs that would disrupt the action of these polymerase enzymes. Such drugs might be able to shut down the translesion DNA polymerase system even more effectively than the RNA-interference approach used in these studies and could help to improve the effectiveness of chemotherapy.

END



ELSE PRESS RELEASES FROM THIS DATE:

Louisiana State University Health Sciences Center research shows fish oil component given up to 5 hours after stroke limits brain damage

2010-11-09
New Orleans, LA – Research led by Dr. Nicolas Bazan, Boyd Professor, Villere Chair, and Director of the Neuroscience Center of Excellence at LSU Health Sciences Center, has shown that Docosahexaenoic acid (DHA), a component of fish oil, is a powerful therapeutic agent that can protect brain tissue and promote recovery in an experimental model of acute ischemic stroke, even when treatment is delayed by up to five hours. These findings not only target a new stroke treatment approach, but also provide vital information about the length of the therapeutic window. The NIH-funded ...

Scientists make advance in dementia research

2010-11-09
The preservation of a protein found in particular synapses in the brain plays a key role in protecting against vascular dementia after a stroke, say researchers at King's College London. The study, funded by the Dunhill Medical Trust, is published today in the 9 November issue of Neurology, the medical journal of the American Academy of Neurology. Researchers say the study findings increase understanding of vascular dementia, and highlight a possible target for future diagnoses and treatment of the condition. Professor Paul Francis, King's College London, said: 'Vascular ...

Hebrew University-developed method for control of malaria applied in Africa

Hebrew University-developed method for control of malaria applied in Africa
2010-11-09
Jerusalem, November 8, 2010 – Research carried out in Mali, West Africa, has demonstrated that a new, safe and uncomplicated insect control method, developed at the Hebrew University of Jerusalem, can bring about a serious decline in malaria-bearing mosquitoes in afflicted regions in the world. The research in Africa was based on work carried out earlier in Israel by researchers at the Kuvin Center for the Study of Tropical and Infectious Diseases at the Hebrew University of Jerusalem that showed how attractants of plant origin (fruit or flowers) with a toxic sugar bait ...

Fat cells reach their limit and trigger changes linked to type 2 diabetes

2010-11-09
Scientists have found that the fat cells and tissues of morbidly obese people and animals can reach a limit in their ability to store fat appropriately. Beyond this limit several biological processes conspire to prevent further expansion of fat tissue and in the process may trigger other health problems. Research funded by the Biotechnology and Biological Sciences Research Council (BBSRC), the Medical Research Council (MRC) and the European Union Sixth Framework Programme, shows that a protein called secreted frizzled-related protein 1 (SFRP1) is produced by fat cells ...

Researchers in Bonn find an 'altruism gene'

2010-11-09
Do you like to do good things for other people? If so, your genes might be responsible for this. At least, the results of a study conducted by researchers of the University of Bonn suggest this. According to the study, a minute change in a particular gene is associated with a significantly higher willingness to donate. People with this change gave twice as much money on average to a charitable cause as did other study subjects. The results have now been published in the journal Social Cognitive & Affective Neuroscience (doi: 10.1093/scan/nsq083). The researchers working ...

Quantum memory for communication networks of the future

Quantum memory for communication networks of the future
2010-11-09
Researchers from the Niels Bohr Institute at the University of Copenhagen have succeeded in storing quantum information using two 'entangled' light beams. Quantum memory or information storage is a necessary element of future quantum communication networks. The new findings are published in Nature Physics. Quantum networks will be able to protect the security of information better than the current conventional communication networks. The cornerstone of quantum communication is a phenomenon called entanglement between two quantum systems, for example, two light beams. ...

Graphene gets a Teflon makeover

2010-11-09
Professor Andre Geim, who along with his colleague Professor Kostya Novoselov won the 2010 Nobel Prize for graphene – the world's thinnest material, has now modified it to make fluorographene – a one-molecule-thick material chemically similar to Teflon. Fluorographene is fully-fluorinated graphene and is basically a two-dimensional version of Teflon, showing similar properties including chemical inertness and thermal stability. The results are this week reported in the advanced online issue of the journal Small. The work is a large international effort and involved ...

Were our tetrapod ancestors deaf?

Were our tetrapod ancestors deaf?
2010-11-09
Many changes in the sensory systems of tetrapods are associated with the water-to-land transition. In hearing, one of the crucial elements in detecting airborne sound is the tympanic ear. Surprisingly, the tympanic ear originated independently in the major tetrapod lineages and relatively late after the terrestrial tetrapods emerged – in the Triassic, more than 100 million years after the origin of tetrapods. The major question raised by the researchers Jakob Christensen-Dalsgaard, Christian Brandt and Magnus Wahlberg, University of Southern Denmark, and Maria Wilson and ...

Privacy safeguards in Canadian military insufficient: Updated rules needed

2010-11-09
Privacy legislation and protocols to safeguard the health information of members of the military are lacking, and the head of Canada's military must take action to ensure health privacy for all staff, states an editorial in the Canadian Medical Association Journal (CAMJ) http://www.cmaj.ca/cgi/doi/10.1503/cmaj.101630. Recent violations at Veterans Affairs Canada of privacy regarding sensitive health information raise questions about the military's ability to protect personal health information. "Few of the world's armed forces provide complete confidentiality of personal ...

Mild painkillers in pregnancy are associated with an increased risk of male reproductive problems

2010-11-09
New evidence has emerged that the use of mild painkillers such as paracetamol, aspirin and ibuprofen, may be part of the reason for the increase in male reproductive disorders in recent decades. Research published in Europe's leading reproductive medicine journal Human Reproduction today (Monday 8 November) shows that women who took a combination of more than one mild analgesic during pregnancy, or who took the painkillers during the second trimester of pregnancy, had an increased risk of giving birth to sons with undescended testicles (cryptorchidism) – a condition that ...

LAST 30 PRESS RELEASES:

Study tracks chromium chemistry in irradiated molten salts

Scientists: the beautiful game is a silver bullet for global health

Being physically active, even just a couple of days a week, may be key to better health

High-fat diet promote breast cancer metastasis in animal models

A router for photons

Nurses and AI collaborate to save lives, reduce hospital stays

Multi-resistance in bacteria predicted by AI model

Tinker Tots: A citizen science project to explore ethical dilemmas in embryo selection

Sensing sickness

Cost to build multifamily housing in California more than twice as high as in Texas

Program takes aim at drinking, unsafe sex, and sexual assault on college campuses

Inability to pay for healthcare reaches record high in U.S.

Science ‘storytelling’ urgently needed amid climate and biodiversity crisis

KAIST Develops Retinal Therapy to Restore Lost Vision​

Adipocyte-hepatocyte signaling mechanism uncovered in endoplasmic reticulum stress response

Mammals were adapting from life in the trees to living on the ground before dinosaur-killing asteroid

Low LDL cholesterol levels linked to reduced risk of dementia

Thickening of the eye’s retina associated with greater risk and severity of postoperative delirium in older patients

Almost one in ten people surveyed report having been harmed by the NHS in the last three years

Enhancing light control with complex frequency excitations

New research finds novel drug target for acute myeloid leukemia, bringing hope for cancer patients

New insight into factors associated with a common disease among dogs and humans

Illuminating single atoms for sustainable propylene production

New study finds Rocky Mountain snow contamination

Study examines lactation in critically ill patients

UVA Engineering Dean Jennifer West earns AIMBE’s 2025 Pierre Galletti Award

Doubling down on metasurfaces

New Cedars-Sinai study shows how specialized diet can improve gut disorders

Making moves and hitting the breaks: Owl journeys surprise researchers in western Montana

PKU Scientists simulate the origin and evolution of the North Atlantic Oscillation

[Press-News.org] Massachusetts Institute of Technology IDs new cancer drug target
Shutting down enzyme that controls DNA repair could boost effects of traditional chemo drugs